An influenza HA mRNA-LNP vaccine induces potent responses in newborn nonhuman primates that enhance protection from challenge
View abstract on PubMed
Summary
This summary is machine-generated.Newborns are highly vulnerable to influenza. An mRNA-LNP vaccine demonstrated robust antibody responses and reduced disease severity in newborn non-human primates, offering potential protection for infants.
Area Of Science
- Immunology
- Vaccinology
- Virology
Background
- Newborns face significant health risks from influenza due to immature immune systems and lack of vaccines.
- Existing vaccines are not licensed for infants under six months, leaving them unprotected.
- Messenger RNA-Lipid Nanoparticle (mRNA-LNP) vaccines show promise in inducing immune responses in vulnerable populations.
Purpose Of The Study
- To evaluate the efficacy of an influenza hemagglutinin mRNA-LNP vaccine in newborn non-human primates (NHP).
- To assess the vaccine's ability to elicit protective immune responses in a model closely resembling human infants.
Main Methods
- Newborn NHPs were administered an influenza hemagglutinin mRNA-LNP vaccine.
- Vaccine efficacy was assessed by measuring antibody responses and viral load after influenza challenge.
- Immune responses were characterized for robustness and functionality.
Main Results
- The HA mRNA-LNP vaccine induced strong, multi-functional antibody responses in newborn NHPs.
- Vaccinated NHPs exhibited significantly reduced viral loads post-challenge.
- Disease severity was notably decreased in the vaccinated group compared to controls.
Conclusions
- Influenza hemagglutinin mRNA-LNP vaccination is effective in protecting newborn NHPs against influenza infection.
- This platform holds significant potential for protecting the vulnerable infant population against influenza.
- Further development could address critical vaccine coverage gaps for infants under six months.
Related Concept Videos
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
Overview
Vaccination is the administration of antigenic material from pathogens to confer immunity against a specific microorganism. Vaccination primes the immune system to recognize and mount an immune response faster and more effectively if the real pathogen is encountered. Vaccinations are one of the most efficient ways to protect both individual humans and the general public from disease. A growing anti-vaccination skepticism risks the successes of vaccination programs that helped reduce...

